Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label

Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB

Outcomes of meningococcal serogroup B disease in children after

Immunogenicity and safety of a quadrivalent meningococcal tetanus

Immunogenicity and safety of a quadrivalent meningococcal tetanus

Safety Profile MENVEO [Meningococcal (Groups A, C, Y and W-135

Prevention and Control of Meningococcal Disease

Available meningococcal vaccines.

Safety and immunogenicity of an investigational quadrivalent

Full article: Immunogenicity and safety of a quadrivalent

Safety Profile MENVEO [Meningococcal (Groups A, C, Y and W-135

Full article: Immunogenicity and safety of a booster dose of a

Meningococcal serogroups A, C, W-135, and Y tetanus toxoid